ZLAB

Zai Lab Limited American Depositary Shares
Data: 2026-05-22
$18.61
Price
-2.57%
Change
$44.34
52W High
$15.96
52W Low

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Quick Stats
May 22, 2026

49.1

AI Score

HOLD

0.47

Volume Ratio

May 12, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

ZLAB Stock Summary

Last updated May 22, 2026

ZLAB is currently trading at $18.61, positioned below its 200-day moving average of $23.33, suggesting bearish momentum. The stock has a 52-week range of $15.96 to $44.34.

Technical Analysis: The 50-day moving average stands at $20.36, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.185, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.112, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ZLAB at 49.1/100 with a HOLD recommendation.

ZLAB (Zai Lab Limited American Depositary Shares) Indicators

Last updated May 22, 2026

Indicator Value
RSI(14) 40.185
CMF (20) -0.112
ROC (10) -0.269
ADX (14) 17.004
Indicator Value
MACD (12,26,9) -0.633
AROONOSC (14) -85.714
WILLAMS %R (14) -84.818
MFI (14) 42.96
ZLAB Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ZLAB Price vs Max Options Open Interest
ZLAB Max Change In Options Open Interest

ZLAB Options - Sort by Max open Interest (near term)

22nd May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ZLAB Daily Out of Money Options - Sort by Max open Interest (near term)

22nd May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ZLAB Daily In the Money Options - Sort by Max open Interest (near term)

22nd May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ZLAB Most Active Options by Volume(near term)

22nd May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Zai Lab Limited American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ZLAB Moving Averages Analysis

ZLAB (Zai Lab Limited American Depositary Shares) Simple Moving Averages

Moving Averages are last updated May 22, 2026

Days MA
10 19.43
20 20.19
30 21.17
50 20.36
100 19.46
200 23.33

ZLAB Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 2.1 billion
Earnings/Share ($) -1.7
Net Proft Margin (%) -0.3929
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.1629
EPS Estimate Next Year ($) -1.7463
WallStreet Target Price ($) 33.7775
Most Recent Quarter